Modeling Human Pacemaker Maturation with PSC-Derived Assembloids

Study Background and Research Question

The human sinoatrial node (SAN) is responsible for initiating and regulating heart rhythm through its intrinsic pacemaker cells, but its development and innervation are challenging to study due to limited human tissue access and complex 3D microanatomy. Traditional animal models provide valuable insights, yet species-specific differences in electrophysiology and autonomic regulation limit their translational relevance. In vitro models using human pluripotent stem cell (hPSC)-derived pacemaker cells have advanced the field, but most fail to recapitulate the spatial organization and neuro-cardiac interactions critical for authentic SAN maturation and function. The reference study addresses this gap by asking: Can a human stem cell-based assembloid system be engineered to model intrinsic neural modulation and maturation of pacemaker systems in vitro?

Key Innovation from the Reference Study

The central innovation is the creation of a tri-assembloid platform that integrates hPSC-derived sinoatrial node organoids (SANOs), cardiac ganglionated plexus organoids (CGPOs), and atrial-like cardiac organoids. This system models the neuro-cardiac interface, specifically allowing the study of neuron-to-pacemaker signaling pathways that drive human SAN maturation. By incorporating spatial transcriptomics of human SAN tissue, the study maps cell-type-specific interactions and identifies novel signaling axes, such as CGPO-derived prosaposin (PSAP) engaging the SAN-enriched receptor GPR37, critical for pacemaker development and functional maturation.

Methods and Experimental Design Insights

The researchers differentiated hPSCs into three distinct cardiac organoid types:

• SAN organoids (SANOs), mimicking the head, tail, and transitional SAN pacemaker cell subpopulations, defined by markers such as SHOX2, ISL1, and TBX3.
• Cardiac ganglionated plexus organoids (CGPOs), representing autonomic neural inputs, particularly the right atrial ganglionated plexus (RAGP).
• Atrial-like cardiac organoids, supporting pacemaker-to-atrial conduction modeling.

These organoids were assembled into a tri-assembloid system, recapitulating the spatial and functional relationships observed in the human heart. The platform was characterized using single-cell and spatial transcriptomics, immunostaining, and high-resolution electrophysiological mapping to assess cell identity, connectivity, and pacemaker function. Functional interrogation of neural modulation was achieved by manipulating CGPO-SANO signaling, with particular focus on the PSAP-GPR37 pathway.

Protocol Parameters

• Organoid differentiation: Sequential differentiation and patterning of hPSCs into SAN-, CGPO-, and atrial-like lineages using stage-specific growth factors and signaling modulators.
• Assembloid assembly: Integration of pre-matured SANOs, CGPOs, and atrial organoids in defined ratios (typically 1:1:1 or optimized based on preliminary coupling efficiency).
• Neural modulation assays: Application of pharmacological agents or genetic perturbation (e.g., PSAP or GPR37 knockdown) to assess neuron-to-pacemaker signaling effects.
• Electrophysiological recording: Optical mapping and patch-clamp techniques to measure spontaneous firing rate, action potential propagation, and conduction velocity across the assembloid.
• Spatial transcriptomics: Integration of spatially resolved gene expression data from human SAN tissue for benchmarking in vitro maturation states.

Core Findings and Why They Matter

The tri-assembloid system successfully recapitulates key molecular, structural, and functional features of human SAN development, including:

• Generation of heterogeneous SAN pacemaker cell subtypes and robust pacemaker-to-atrial conduction dynamics.
• Demonstration that intrinsic neural inputs from CGPOs modulate SAN automaticity, firing rate, and conduction properties, paralleling physiological autonomic regulation.
• Identification of a neuron-to-pacemaker signaling program mediated by CGPO-derived prosaposin and GPR37, required for SAN maturation and functional output.

These findings provide a powerful, human-specific platform for dissecting the mechanisms of pacemaker formation, neuro-cardiac crosstalk, and disease-associated conduction disorders. The ability to manipulate beta-adrenergic receptor signaling, for instance, enables detailed study of the cAMP/PKA pathway and its role in pacemaker physiology.

Comparison with Existing Internal Articles

This reference study builds on prior work, notably the tri-assembloid workflow outlined in Modeling Human Pacemaker Maturation with PSC-Derived Cardiac Assembloids, but advances the field by integrating spatial transcriptomics and directly modeling neuron-to-pacemaker signaling. The approach complements internal resources such as Isoproterenol Sulfate Dihydrate in Human Pacemaker Maturation, which details precision modulation of beta-adrenergic receptor signaling in similar assembloid models. Additionally, the mechanistic insights into PSAP-GPR37 signaling and functional neuro-cardiac integration distinguish this study from platforms that focus solely on cardiac or neural lineages in isolation, as described in Modeling Human Pacemaker Maturation with SAN-Plexus Assembloids.

Limitations and Transferability

While the tri-assembloid system offers unprecedented access to human-specific pacemaker development and neuro-cardiac interactions, several limitations remain. The in vitro nature of the model may not fully capture the biomechanical and systemic cues present in vivo, and long-term maturation beyond early developmental stages is still under active investigation. The complexity of assembling and maintaining functional neural-cardiac-atrial networks also requires careful optimization, as highlighted in protocol-focused resources. Furthermore, inter-individual variability in hPSC lines and differentiation efficiency may impact reproducibility and scalability for high-throughput applications.

Research Support Resources

To enable functional interrogation of beta-adrenergic receptor signaling and cAMP/PKA pathway modulation in similar human assembloid models, researchers can employ Isoproterenol sulfate dihydrate (SKU C6402), a well-characterized non-selective beta-adrenergic agonist. This compound supports precise control of GPCR signaling in cardiovascular research, as detailed in the internal protocol guide. For consistent results, attention should be paid to isoproterenol sulfate solubility and storage guidelines as outlined by APExBIO. This integration of advanced assembloid systems with established research tools will continue to drive mechanistic discoveries in human cardiac development and disease modeling.